Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-20-006361

Chairman sold 23,456 shares at an average $57.97 ($1,359,849)

  • Chairman gave up 8,749 shares (to pay taxes)
  • Chairman acquired 16,223 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-26 Shares withheld for taxes : show line 1 in the form −2,365 $59.91 $141,687 1,482,663 D
2020-02-26 Exercise or conversion : show line 2 in the form +6,429 1,489,092 D
2020-02-26 Shares withheld for taxes : show line 3 in the form −2,530 $59.91 $151,572 1,486,562 D
2020-02-26 Sale : show line 4 in the form −13,619 $58.70 $799,435 1,472,943 D
2020-02-27 Exercise or conversion : show line 5 in the form +9,794 1,482,737 D
2020-02-27 Shares withheld for taxes : show line 6 in the form −3,854 $58.42 $225,151 1,478,883 D
2020-02-27 Sale : show line 7 in the form −9,837 $56.97 $560,414 1,469,046 D
Open-market sales · 23,456 sh · avg $57.97 · $1,359,849

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-02-26 Exercise or conversion : show line 8 in the form Restricted Stock Unit −6,429 47,774 D
2020-02-27 Exercise or conversion : show line 9 in the form Restricted Stock Unit −9,794 37,980 D
Loading xslF345X03/doc4.xml…